{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiac7iivm3wypc63qsj6wmy2cuooinkghfbfdt6hwuilvnjfimo7ye",
    "uri": "at://did:plc:k523mgjgnwrjdnvw6jmck5ar/app.bsky.feed.post/3mhsytphq24e2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie4iydo7st4pg57n5wjdbpkaaacwqdhucky7r525rtww7olcp3njq"
    },
    "mimeType": "image/png",
    "size": 413279
  },
  "description": "While traditional independent pharmacies are closing their doors, new cost-plus pharmacies are opening theirs. The cost-plus model is a radically simplified model that provides unmatched transparency into drug pricing.",
  "path": "/cost-plus-rewriting-the-prescription-for-drug-pricing/",
  "publishedAt": "2026-03-24T16:32:37.000Z",
  "site": "https://www.ptmreview.com",
  "tags": [
    "Subscribe now"
  ],
  "textContent": "Pharmacies today operate within a highly intricate and often unpredictable drug-pricing ecosystem. While pharmacy benefit managers (PBMs) play a central role in negotiating prices and managing formularies, the layers of rebates, reimbursement schedules, and administrative fees can make it difficult for pharmacies to anticipate their margins — or even cover their costs. For many independent pharmacies, this complexity translates into financial strain, operational inefficiencies, and limited flexibility to serve patients in a transparent and sustainable way.\n\nThe fragmented and nontransparent system can have two different patients picking up the same medication, but paying wildly different prices due to insurance coverage, formulary placement, and/or negotiated rebates — none of which are transparent to the patient. Pharmacies oftentimes find themselves caught in this crossfire, resulting in reimbursement below acquisition cost.\n\nThey say necessity is the mother of invention. A new model has emerged to not only sustainably operate a pharmacy but also focus on the most important aspect of healthcare, the patient. The cost-plus model is a radically simplified model that provides unmatched transparency into drug pricing. There are no hidden rebates, tiered formularies, or surprise clawbacks.\n\n* * *\n\n### Discover how the **Cost-Plus Pricing Model** is helping pharmacies reclaim their margins and restore patient trust.\n\n_Read the full article to learn:_\n\n  * **The Blueprint of Cost-Plus:** How a simplified \"acquisition + markup\" model eliminates hidden PBM fees and clawbacks.\n  * **The Team Cuban Card Opportunity:** How to leverage Mark Cuban’s affiliate network to attract new cash-pay patients.\n  * **Navigating the Transition:** Strategic advice on managing PBM contracts while moving toward a transparent pricing structure.\n  * **Technology & Tools:** The essential software features needed to manage real-time acquisition costs and online price transparency.\n\n\n\n* * *\n\n### This post is for subscribers only\n\nBecome a member to get access to all content\n\nSubscribe now",
  "title": "Cost-Plus: Rewriting the Prescription for Drug Pricing",
  "updatedAt": "2026-03-24T16:32:37.915Z"
}